RGNX

Regenxbio Inc

$12.17

0.10 (0.85%) Today

0.19 (1.59%) After-hours

— up— down

Market Cap

$612M+45.6%

Revenue (TTM)

$86.60M-44.0%

Net Income (TTM)

$-289,003,000

$-289,003,000

EPS (TTM)

-5.59

-5.59

Shares Out

51.70M

51.70M

Open

$11.85

$11.85

Previous Close

$11.83

$11.83

Day Range

$11.63 – $12.26

$11.63 – $12.26

52-Week Range

$5.46 – $16.19

$5.46 – $16.19

Beta

0.85

0.85

Volume

1.08M

1.08M

Avg Volume

1.42M

1.42M

Analyst Rating

Buy

Buy

Exchange

NASDAQ NMS - GLOBAL MARKET

NASDAQ NMS - GLOBAL MARKET

About RGNX

Related

News

REGENXBIO Announces First Patient Dosed In Phase IIb/III NAAVIGATE Clinical Trial Of Investigational Surabgene Lomparvovec In Diabetic Retinopathy Using Suprachoroidal Delivery; REGENXBIO To Receive $100M From Abbvie For This Milestone

Benzinga · 1d ago

Regenxbio: 'Strong Buy' On FDA Course Reversal For NAVSUNLI And Potential AA DMD Filing

SeekingAlpha · 2d ago

HC Wainwright & Co. Reiterates Buy on Regenxbio, Maintains $26 Price Target

Benzinga · 6d ago

REGENXBIO Completes Dosing In Its Confirmatory Study Of RGX-202 Gene Therapy For Duchenne Muscular Dystrophy

Benzinga · 6d ago